Single-vesicle profiling advances liquid biopsies for clinical use

Extracellular vesicles (EVs) are tiny, membrane-bound particles released by nearly all cells, carrying proteins, RNA, lipids, and other biological cargo that reflect the condition of their parent cells. Because these vesicles circulate in blood, urine, and other body fluids, scientists identify them as promising biomarkers for diagnosing diseases without the need for invasive biopsies. This approach, known as liquid biopsy, offers a less intrusive alternative to traditional tissue sampling. However, current laboratory methods such as Western blotting and ELISA analyze EVs in bulk. This process averages signals across millions of particles, which often results in missing rare but clinically important subpopulations of vesicles. The article highlights how single-vesicle profiling could overcome these limitations by providing more detailed and accurate data. By focusing on individual particles rather than bulk averages, this advanced technique aims to push liquid biopsies closer to everyday clinical use, potentially revolutionizing disease diagnosis and monitoring through non-invasive means.